Phase II study of neoadjuvant anastrozole and concurrent radiotherapy for postmenopausal breast cancer patients

Backgrounds The aim of this study was to assess the efficacy and safety of neoadjuvant anastrozole and radiation in postmenopausal breast cancer patients with hormone-receptor-positive tumors. In addition, we assessed the predictive factors for clinical and pathological response for concurrent anastrozole and radiotherapy.